APM Annual Conference
What’s New in 2025?
Four Specialized Tracks:
Track 1 – 2025 WIN Symposium: Progress and Challenges in Precision Oncology
Presented in partnership with Advancing Precision Medicine
As the official 2025 WIN Symposium, this dedicated track will explore the evolving landscape of precision oncology, highlighting both groundbreaking advances and the ongoing challenges of translating molecular insights into clinical impact. Curated by the WIN Consortium, the program will feature global leaders in cancer research, diagnostics, and therapeutic innovation—offering a comprehensive view of how precision medicine is reshaping oncology across tumor types and care settings.
Track 2 – Day 1 – Multi-Omics Integration, Day 2 – Precision Medicine Outside of Oncology
From genomics and transcriptomics to proteomics and metabolomics—this track highlights how multi-layered data is revolutionizing systems biology and clinical decision-making.
Diving into applications across cardiovascular, neurology, rare disease, infectious disease, and other therapeutic areas where precision tools are reshaping clinical practice.
Why Attend?
- Cutting-Edge Innovation: Explore AI-powered solutions, multi-omics workflows, clinical trial design, and real-world implementation.
- Renowned Speakers: Hear from global thought leaders in translational research, biotech innovation, and personalized therapeutics.
- Dynamic Format: Keynotes, fireside chats, panels, and audience-interactive discussions across four concurrent tracks.
- Unmatched Networking: Collaborate with scientists, startups, executives, regulators, and investors shaping tomorrow’s care.
- Philadelphia Advantage: Centrally located near premier academic institutions, hospitals, incubators, and venture capital networks.
Who Should Attend?
Researchers, clinicians, data scientists, regulatory experts, startup founders, investors, tech transfer professionals, and healthcare leaders.